Cureous Labs, a Bengaluru-based med-tech startup, secured ₹1.66 crore in seed funding from Inflection Point Ventures and Anthill Ventures. The funds will scale manufacturing of Eturnal, an automated patient repositioning system, expand the team, and open a disinfection center. Founded by Asish Mohandas, the startup targets hospitals and home care, addressing an $8.34B Indian market.
Trending
- Acko Taps Top Banks for H1 2027 IPO Target
- Fairdeal.Market Secures US$15M to Scale B2B Quick Commerce Across India
- India’s Startup IPO Surge: 48+ Listings Set to Unlock INR 50,000 Cr in 2026
- Indian Startup IPO Surge Expected by 2026 Amid Market Reset
- IIT Madras Director Unfazed by India’s AI Sovereignty Concerns
- Flipkart Bolsters Leadership with Key VP Appointments
- IEA Warns Current Oil Crisis Exceeds Past Shocks
- HomeEssentials Secures $7.7M to Fuel Retail Expansion


